A discrete choice experiment for evidence-based decision-making to Explore Willingness to pay for Covid-19 vaccination

Author:

Tran Quang Vinh1,Nguyen Tram Thi Huyen2,Nguyen Hiep Thanh1,Nguyen Binh Thanh3,Pham Van Nu Hanh3,Anuratpanich Luerat4,Vu Truong Lam1,Ta Anh Ngoc Phuong1,Nguyen Hieu Thi Thanh1,Nguyen Chau Duc Quynh1,Nguyen Pol1,Vo Nam Xuan5,Truong Uyen My Thuc2,Tang Hong Kim1,Phung Nhat Duc1,Vo Trung Quang1

Affiliation:

1. Pham Ngoc Thach University of Medicine

2. Ear-Nose-Throat Hospital in Ho Chi Minh city

3. Hanoi University of Pharmacy

4. Mahidol University

5. Ton Duc Thang University

Abstract

Abstract Covid-19 pandemic has caused a massive challenge for global healthcare systems. The longtime solution to prevent the spread of virus is to develop an effective vaccine. To com (WTP). The objective of the present study was to explore the WTP of people aged over 18 for Covid-19 vaccination through a discrete choice experiment (DCE) for evidence-based decision-making. A cross-sectional survey was performed during two mid-weeks in May 2020 in six southeastern provinces in Vietnam. A self-design three-part questionnaire was used to investigate the community. A DCE was designed with twelve vaccine profiles, each one involved four attributes, protection efficacy, duration, side effects and out-of-pocket cost. A binary logistic regression model was applied to predict the probability of choosing a given vaccine. Protection duration posed the highest effect on vaccine choice (prevalence weight 1.2109). The marginal WTP for 10-year protection is US$531.77 (95% CI: 284.31–1485.58). If the vaccine improved to 95% protection for 10 years and had no side effects, the WTP increased to $1466.79. When the self-paid cost increased from US$12.5 to 200, the probability decrease dramatically decreased approximately 21%. This study resulted a high value that southern Vietnamese residents were willing to pay for a vaccine against Covid-19. These findings support decision makers in the implementation of vaccine program in the future.

Publisher

Research Square Platform LLC

Reference27 articles.

1. Ben, F.: Moderna delivers first human data for a coronavirus vaccine. 2020/5/18 [cited 2020 18/06]; Available from: (2020). https://www.biopharmadive.com/news/moderna-coronvirus-vaccine-first-study-results/578109/

2. Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel;Bogoch II;J. Travel Med.,2020

3. Dowdy, S., Wearden, S., Chilko, D.: Statistics for research, vol. 512. John Wiley & Sons (2011)

4. Florian, B., et al.: Willingness to Pay for a for a Potential Vaccine Against SARS-CoV-2 / COVID-19 Among Adult Persons. [cited 2020 May 15]; Available from: (2020). https://assets.researchsquare.com/files/rs-32595/v1/2d6a53f3-37b4-49aa-8b79-b5b717b445cb.pdf

5. General Statistic Office of Vietnam:. Statistics: Population and Employment. [June 15]. Available from: (2020). https://www.gso.gov.vn/default.aspx?tabid=714

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3